Retrospective Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Nov 7, 2017; 23(41): 7415-7424
Published online Nov 7, 2017. doi: 10.3748/wjg.v23.i41.7415
Table 4 Survival rates of hepatocellular carcinoma patients in different groups
GroupOS rate (%)
RFS rate (%)
1 yr2 yr3 yr4 yrP1 yr2 yr3 yr4 yrP
MVI (-), TACE (-)98.891.582.882.80.87280.770.161.255.90.974
MVI (-), TACE (+)94.291.987.687.683.071.861.9NA
MVI (+), TACE (-)81.365.758.853.90.01952.041.133.728.40.002
MVI (+), TACE (+)92.786.573.167.572.158.354.930.9